Verrica Pharmaceuticals Inc. Common Stock (VRCA) is a publicly traded Healthcare sector company. As of September 8, 2026, VRCA trades at $5.40 with a market cap of $91.05M and a P/E ratio of -3.03. VRCA moved +0.00% today. Year to date, VRCA is -36.22%; over the trailing twelve months it is +3.82%. Its 52-week range spans $3.28 to $9.82. Analyst consensus is strong buy with an average price target of $13.67. Rallies surfaces VRCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VRCA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.40 |
| Market Cap | $91.05M |
| P/E Ratio | -3.03 |
| EPS | $-1.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.82 |
| 52-Week Low | $3.28 |
| Volume | 2.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $30.32M |
| Net Income | $-31.18M |
| Gross Margin | 0.00% |
4 analysts cover VRCA: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.67.